Abbott Laboratories (ABT) Depreciation and Depletion (2012 - 2015)

Abbott Laboratories has disclosed Depreciation and Depletion across 3 years of filings, most recently posting $11.0 million for Q4 2015.

• In Q4 2015, Depreciation and Depletion changed N/A year-over-year to $11.0 million; the TTM figure through Dec 2015 stood at $45.0 million (changed N/A YoY), while the FY2017 annual figure was $2.0 million, changed 0.0% from the prior year.
• Depreciation and Depletion came in at $11.0 million for Q4 2015 at Abbott Laboratories, up from $9.0 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $89.0 million in Q4 2012 to a low of $2.0 million in Q2 2012.
• Average Depreciation and Depletion over 3 years is $17.1 million, with a median of $8.5 million recorded in 2012.
• The largest YoY upside for Depreciation and Depletion was 300.0% in 2013 against a maximum downside of 80.9% in 2013.
• Over 3 years, Depreciation and Depletion stood at $89.0 million in 2012, then tumbled by 80.9% to $17.0 million in 2013, then sank by 35.29% to $11.0 million in 2015.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $11.0 million in Q4 2015, $9.0 million in Q3 2015, and $17.0 million in Q4 2013.